Found: 7 articles
Article | Edition |
---|---|
T.N. Trofimtseva, S.K. Yarovoy, A.A. Gritskevich, T.P. Baytman
Efficacy of the combination of pembrolizumab and axitinib in the treatment of renal cell carcinoma associated with chronic kidney disease
|
№11 / 2023 |
A.I. Semenova, S.A. Protsenko, G.M. Teletaeva, D.Kh. Latipova, A.V. Novik
Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma
|
№11-12 / 2022 |
M.S. Sayapina, D.A. Nosov
MODERN APPROACHES TO TREATMENT OF RENAL CELL CARCINOMA ACCORDING TO THE MATERIALS OF THE VII INTERNATIONAL CONFERENCE OF RENAL CANCER EXPERTS (CORE, 2016)
|
№8 / 2016 |
V.A. Gorbunova
EVEROLIMUS (AFINITOR): NEW POTENTIALS FOR THE THERAPY OF MALIGNANT TUMORS
|
№8 / 2014 |
Yu Alyaev, E. V. Shpot
Renal Cell Carcinoma. Past, Present And Future
|
№18-19 / 2010 |
M.I. Volkova
Conference Of Renal Cancer Experts: A Review Of Materials
|
№17 / 2010 |
V.I. Borisov
Effectiveness Of Afinitor® (everolimus) For Metastatic Kidney Cancer
|
№17 / 2010 |